Dong-E-E-Jiao Co.,Ltd.

Equities

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-02-22 pm EST 5-day change 1st Jan Change
54.95 CNY -1.66% Intraday chart for Dong-E-E-Jiao Co.,Ltd. -4.93% +11.42%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million. CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024. CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million. CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan. CI
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60% MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Nine Months Ended 30 September 2023 CI
Dong-E-E-Jiao's H1 Attributable Profit Surges 72% MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Dong-E-E-Jiao Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on June 21, 2023 CI
Dong-E-E-Jiao Vice President, CFO Resign MT
Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2022 CI
Dong-E-E-Jiao's Q1 Profit Doubles; Shares Fall 4% MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dong-E-E-Jiao Estimates Higher Q1 Attributable Profit MT
Dong-E-E-Jiao Sees Up to 114% Profit Jump in Q1 MT
Dong-E-E-Jiao Co.,Ltd. Proposes Dividend for the Year 2022 CI
Dong-E-E-Jiao Chairman Resigns MT
Dong-E-E-Jiao Expects Up to 810 Million Yuan in 2022 Profit; Shares Rise 4% MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022 CI
Dong-E-E-Jiao's January-September Profit Increases; Stock Rises 4% MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Dong-E-E-Jiao Sees Nine-Month to September Profit Rise Up to 86% MT
Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Nine Months Ended 30 September 2022 CI
Chart Dong-E-E-Jiao Co.,Ltd.
More charts
Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
54.95 CNY
Average target price
62.84 CNY
Spread / Average Target
+14.35%
Consensus
  1. Stock
  2. Equities
  3. Stock Dong-E-E-Jiao Co.,Ltd. - Shenzhen S.E.
  4. News Dong-E-E-Jiao Co.,Ltd.
  5. UBS Adjusts Dong-E E-Jiao’s Price Target to 40.75 Yuan From 39.30 Yuan, Keeps at Neutral
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW